Sleep Apnea Pill Data Presented at ATS 2021: ‘These Data Reinforce the Potential of Pharmacotherapy in Treating OSA’
The administration of reboxetine plus oxybutynin before bedtime greatly decreased OSA severity and increased next-day vigilance after 1 week.